Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab

By sjmartinez • May 13, 2025

Kim GH, Zhang X, Brown MS, Poole L, Goldin J. Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 2025 May 12;15(5):e094559. doi: 10.1136/bmjopen-2024-094559. PMID: 40355288.

Tags: Chest imaging, Computed tomography, interstitial lung disease, Patient reported outcome measures, Publications, Pulmonary Disease, Pulmonary, Critical Care & Sleep Medicine, QUALITATIVE RESEARCH

Bridging gaps throughout a patient’s journey with melanoma: a systematic review

Amarsi A, Xu J, Chan J, Jiang YC, Omar AZ, Meghdadi Y, Doshi A, Xie A, Wu A. Bridging gaps throughout a patient's journey with[...]

Cosmetic Laser Procedures and Nonsurgical Body Contouring in Patients With Skin of Color

Sheppard TK, Quiñonez RL, Burgess CM, Taylor SC, Agbai ON. Cosmetic Laser Procedures and Nonsurgical Body Contouring in Patients With Skin of Color. Cutis. 2025[...]

Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study

Yamamoto K, Bando H, Misumi T, Nishikawa T, Wakabayashi M, Yamazaki K, Maehara Y, Oki E, Saltz LB, Douillard JY, Punt CJ, Koopman M, Van[...]